MedTrace Logo

Unintended Home Injuries in Under-5 Children in Sohag Governorate

NCT05421039 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2022-06-16

No results posted yet for this study

Summary

Child injuries are a major public health problem . Globally, unintended injury is one of the top 15 causes of death across all age groups of children aged؛ 0-19 years, In children under the age of five, the majority of injuries occur in the home.

Injuries is a health concern in every country around the world, affecting both developed and developing countries, causing over 5.8 million deaths per year or 15,000 deaths per day .

A WHO surveillance study conducted in four developing countries showed that Egypt had a prevalence of 32 % of childhood injuries which was the highest one .

The home is the place where children spend most of their time, the home environment is the most common place for childhood injuries

Conditions

  • Unintended Home Injuries in Under-5 Children

Interventions

BEHAVIORAL

Exposure to unintended injuries

After taking a verbal consent , an explanation of the study will be given to the caregivers , those who fulfill the inclusion criteria will be enrolled in the study. Personal interviews by the researcher will be made with individuals or groups (2-4 persons) , participants will be chosen by means of systematic random sampling among visitors ؛ every 3rd or 5th child according to density and flow of attendance . the investigator will fill the questionnaire through personal interview with the caregivers

Sponsors & Collaborators

  • Sohag University

    lead OTHER

Eligibility

Min Age
2 Months
Max Age
5 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-07-01
Primary Completion
2022-12-31
Completion
2023-04-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05421039 on ClinicalTrials.gov